59 related articles for article (PubMed ID: 25906295)
21. The application of dynamic contrast-enhanced MRI and diffusion-weighted MRI in patients with maxillofacial tumors.
Kitamoto E; Chikui T; Kawano S; Ohga M; Kobayashi K; Matsuo Y; Yoshiura T; Obara M; Honda H; Yoshiura K
Acad Radiol; 2015 Feb; 22(2):210-6. PubMed ID: 25442795
[TBL] [Abstract][Full Text] [Related]
22. Quantitative dynamic contrast-enhanced MRI for the assessment of mandibular invasion by squamous cell carcinoma.
Van Cann EM; Rijpkema M; Heerschap A; van der Bilt A; Koole R; Stoelinga PJ
Oral Oncol; 2008 Dec; 44(12):1147-54. PubMed ID: 18485797
[TBL] [Abstract][Full Text] [Related]
23. Voxelwise comparison of perfusion parameters estimated using dynamic contrast enhanced (DCE) computed tomography and DCE-magnetic resonance imaging in locally advanced cervical cancer.
Kallehauge J; Nielsen T; Haack S; Peters DA; Mohamed S; Fokdal L; Lindegaard JC; Hansen DC; Rasmussen F; Tanderup K; Pedersen EM
Acta Oncol; 2013 Oct; 52(7):1360-8. PubMed ID: 24003852
[TBL] [Abstract][Full Text] [Related]
24. Human Papillomavirus and Epidermal Growth Factor Receptor in Oral Cavity and Oropharyngeal Squamous Cell Carcinoma: Correlation With Dynamic Contrast-Enhanced MRI Parameters.
Choi YS; Park M; Kwon HJ; Koh YW; Lee SK; Kim J
AJR Am J Roentgenol; 2016 Feb; 206(2):408-13. PubMed ID: 26797372
[TBL] [Abstract][Full Text] [Related]
25. Dynamic contrast-enhanced magnetic resonance imaging as a predictor of outcome in head-and-neck squamous cell carcinoma patients with nodal metastases.
Shukla-Dave A; Lee NY; Jansen JF; Thaler HT; Stambuk HE; Fury MG; Patel SG; Moreira AL; Sherman E; Karimi S; Wang Y; Kraus D; Shah JP; Pfister DG; Koutcher JA
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1837-44. PubMed ID: 21601373
[TBL] [Abstract][Full Text] [Related]
26. Dynamic contrast-enhanced MRI of nasopharyngeal carcinoma: a preliminary study of the correlations between quantitative parameters and clinical stage.
Zheng D; Chen Y; Chen Y; Xu L; Chen W; Yao Y; Du Z; Deng X; Chan Q
J Magn Reson Imaging; 2014 Apr; 39(4):940-8. PubMed ID: 24108569
[TBL] [Abstract][Full Text] [Related]
27. Slug is a key mediator of hypoxia induced cadherin switch in HNSCC: correlations with poor prognosis.
Zhang J; Cheng Q; Zhou Y; Wang Y; Chen X
Oral Oncol; 2013 Nov; 49(11):1043-50. PubMed ID: 24035721
[TBL] [Abstract][Full Text] [Related]
28. The use of dynamic tracer concentration in veins for quantitative DCE-MRI kinetic analysis in head and neck.
Yuan J; Chow SK; Zhang Q; Yeung DK; Ahuja AT; King AD
PLoS One; 2013; 8(3):e59885. PubMed ID: 23527281
[TBL] [Abstract][Full Text] [Related]
29. Dynamic contrast-enhanced magnetic resonance imaging for characterising nasopharyngeal carcinoma: comparison of semiquantitative and quantitative parameters and correlation with tumour stage.
Huang B; Wong CS; Whitcher B; Kwong DL; Lai V; Chan Q; Khong PL
Eur Radiol; 2013 Jun; 23(6):1495-502. PubMed ID: 23377545
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetic analysis based on dynamic contrast-enhanced MRI for evaluating tumor response to preoperative therapy for oral cancer.
Chikui T; Kitamoto E; Kawano S; Sugiura T; Obara M; Simonetti AW; Hatakenaka M; Matsuo Y; Koga S; Ohga M; Nakamura K; Yoshiura K
J Magn Reson Imaging; 2012 Sep; 36(3):589-97. PubMed ID: 22649040
[TBL] [Abstract][Full Text] [Related]
31. Clinical significance of combined assessment of the maximum standardized uptake value of F-18 FDG PET with nodal size in the diagnosis of cervical lymph node metastasis of oral squamous cell carcinoma.
Matsubara R; Kawano S; Chikui T; Kiyosue T; Goto Y; Hirano M; Jinno T; Nagata T; Oobu K; Abe K; Nakamura S
Acad Radiol; 2012 Jun; 19(6):708-17. PubMed ID: 22484437
[TBL] [Abstract][Full Text] [Related]
32. Correlation of a priori DCE-MRI and (1)H-MRS data with molecular markers in neck nodal metastases: Initial analysis.
Jansen JF; Carlson DL; Lu Y; Stambuk HE; Moreira AL; Singh B; Patel SG; Kraus DH; Wong RJ; Shaha AR; Shah JP; Shukla-Dave A
Oral Oncol; 2012 Aug; 48(8):717-22. PubMed ID: 22366441
[TBL] [Abstract][Full Text] [Related]
33. Assessment of tumor radioresponsiveness and metastatic potential by dynamic contrast-enhanced magnetic resonance imaging.
Øvrebø KM; Gulliksrud K; Mathiesen B; Rofstad EK
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):255-61. PubMed ID: 21816291
[TBL] [Abstract][Full Text] [Related]
34. Phase-based arterial input function measurements in the femoral arteries for quantification of dynamic contrast-enhanced (DCE) MRI and comparison with DCE-CT.
Korporaal JG; van den Berg CA; van Osch MJ; Groenendaal G; van Vulpen M; van der Heide UA
Magn Reson Med; 2011 Nov; 66(5):1267-74. PubMed ID: 21604291
[TBL] [Abstract][Full Text] [Related]
35. Coexpression of hypoxia-inducible factor-1α and glucose transporter-1 is associated with poor prognosis in oral squamous cell carcinoma patients.
Eckert AW; Lautner MH; Schütze A; Taubert H; Schubert J; Bilkenroth U
Histopathology; 2011 Jun; 58(7):1136-47. PubMed ID: 21438910
[TBL] [Abstract][Full Text] [Related]
36. Prediction and monitoring of the response to chemoradiotherapy in oral squamous cell carcinomas using a pharmacokinetic analysis based on the dynamic contrast-enhanced MR imaging findings.
Chikui T; Kawano S; Kawazu T; Hatakenaka M; Koga S; Ohga M; Matsuo Y; Sunami S; Sugiura T; Shioyama Y; Obara M; Yoshiura K
Eur Radiol; 2011 Aug; 21(8):1699-708. PubMed ID: 21394565
[TBL] [Abstract][Full Text] [Related]
37. Dynamic contrast enhancement magnetic resonance imaging (DCE-MRI) for differential diagnosis in head and neck cancers.
Lee FK; King AD; Ma BB; Yeung DK
Eur J Radiol; 2012 Apr; 81(4):784-8. PubMed ID: 21376492
[TBL] [Abstract][Full Text] [Related]
38. Prediction of disease-free survival in patients with squamous cell carcinomas of the head and neck using dynamic contrast-enhanced MR imaging.
Chawla S; Kim S; Loevner LA; Hwang WT; Weinstein G; Chalian A; Quon H; Poptani H
AJNR Am J Neuroradiol; 2011 Apr; 32(4):778-84. PubMed ID: 21349969
[TBL] [Abstract][Full Text] [Related]
39. Differentiation between hypoxic and non-hypoxic experimental tumors by dynamic contrast-enhanced magnetic resonance imaging.
Gulliksrud K; Øvrebø KM; Mathiesen B; Rofstad EK
Radiother Oncol; 2011 Mar; 98(3):360-4. PubMed ID: 21262548
[TBL] [Abstract][Full Text] [Related]
40. An exploratory pilot study into the association between microcirculatory parameters derived by MRI-based pharmacokinetic analysis and glucose utilization estimated by PET-CT imaging in head and neck cancer.
Bisdas S; Seitz O; Middendorp M; Chambron-Pinho N; Bisdas T; Vogl TJ; Hammerstingl R; Ernemann U; Mack MG
Eur Radiol; 2010 Oct; 20(10):2358-66. PubMed ID: 20443116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
